Brianna R Altman
Biographic Data
| ID | 1929228 |
|---|---|
| NAME | Brianna R Altman |
| GIVEN NAMES | Brianna R |
| FAMILY NAME | Altman |
| SIGNATURE | ALTMAN B R |
| AFFILIATIONS | Department of Psychology, University at Albany, State University of New York, Albany, NY, USA |
| ORCID | 0000-0001-9254-2939 |
| VERIFIED | Yes |
| TOTAL WORKS | 14 |
| TOTAL CITATIONS | 2 |
| WORKS AS AUTHOR | 14 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 1 |
Client treatment preferences in psychedelic-assisted therapy for depression in participants with depressive symptoms
Background and AimsResearch on psychedelic-assisted therapy (PAT), a promising treatment option for major depression, has not revealed if potential clients show preferences about the demographic characteristics of providers comparable to those common in other forms of psychotherapy. Previous work suggests that honoring comparable client preferences can enhance therapeutic outcomes. This study aims to investigate the importance ratings for a same-…
Methodological approach for an integrated female-specific study of anxiety and smoking comorbidity
Two primary ovarian hormones that fluctuate across the female menstrual cycle-estradiol and progesterone-have been independently linked in separate literatures to nicotine reinforcement and anxiety psychopathology. We identify existing methodological limitations in these literatures, describe an example protocol that was developed to address such limitations, highlight case examples, and offer insights on the resulting advantages and challenges. …
How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression
Promising outcomes of Psilocybin-Assisted Therapy (PAT) for depression have generated concerted efforts to replicate, extend, and refine protocols to maximize efficacy. Psychotherapy research reveals that clients benefit most when important components of treatment align with their personal preferences. One open question related to PAT concerns the importance of the psilocybin experience of the guides (trained professionals present during acute ef…
Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression
Depression treatments succeed with many but leave others unimproved, and they can generate concerns about side effects, time, and cost. Psilocybin has generated media attention and empirical support for antidepressant effects, but lay impressions of its effectiveness are unclear. Although perceptions of treatment credibility contribute to outcome, beliefs about the credibility of psilocybin-assisted therapy (PAT) among potential patients remain u…
Replicating the Dimensional Structure of Cannabis Problems
Objective: This study employed taxometric procedures to replicate a previous report of the dimensional structure of problems related to cannabis consumption. Method: Over 4,000 cannabis users completed an assessment of psychological, social, occupational, and physical harms (the Marijuana Problems Scale). Three taxometric procedures (MAMBAC, MAXEIG, and L-Mode) compared the current data to simulations with a base rate of problematic cannabis use …
Age-Related Differences in Cannabis Product Use
Cannabis use varies with age and gender, but less is known regarding specific product choices. Previous work suggests that older adults are inclined to stick to the more "classic" and familiar, while "novel" products are more likely to appeal to younger populations. We examined cross-sectional, retrospective data to determine whether the type of cannabis products used varied according to participant age ( N = 1406, 71.3% female). The extensive li…
Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression
Ketamine, a novel treatment for depression, has generated considerable interest and research. Few experiments address lay impressions of the credibility of ketamine treatment relative to another popular intervention for depression, CBT. Over 500 participants with depressive symptoms read descriptions of CBT, ketamine, and a treatment that combined the two. Descriptions included pros and cons of each approach. Participants found the combination tr…
Symptom specificity of ayahuasca's effect on depressive symptoms
BackgroundAyahuasca's effects on symptoms of depression have generated considerable optimism. Clients frequently report more concern about some symptoms than others, and available treatments alter symptoms differentially. Few studies address the symptom specificity of this psychoactive brew.AimsWe examined self-reported effects of ayahuasca on the individual symptoms of depression assessed by the 10-item short-form of Center for Epidemiological S…
Expectancies about the Effects of Cannabis Use on Eating Disorder Symptoms
Background: Substance use, specifically cannabis use, is common among individuals with eating disorder (ED) symptoms; however, few studies have specifically explored the relation between EDs and cannabis use. Purpose: The present study examined expectancies about the impact of cannabis on cognitive, affective and behavioral ED symptoms. Additionally, this study explored associations between cannabis-related expectancies, cannabis use and cannabis…
Confirming Savoring’s Link to Fewer Cannabis Problems
Savoring has covaried inversely with cannabis problems and moderated the association between cannabis use and negative consequences related to use. Research has not yet addressed the acceptability of savoring interventions for cannabis users. The present study aimed to replicate the finding of savoring as a protective factor against problems for cannabis users. The second aim of the study was to examine preferences for a savoring intervention amo…
The Novelty of Ayahuasca Scale and the prediction of intentions to use
ObjectiveGiven the growing popularity of ayahuasca and other hallucinogens, we sought to identify related expectancies and their role in why people might use this psychoactive brew rather than classic hallucinogens like LSD or psilocybin.MethodExperienced users (N = 139) completed an online survey about their use of hallucinogens (including ayahuasca), how their ayahuasca experiences differed from those with other hallucinogens, as well as their …
Cannabis Expectancies for Sleep
Up to 35% of adults in the United States suffer from sleep disturbances, which covary with a host of negative mental and physical health outcomes. Previous research suggests that cannabis' sedative effects may be associated with improved sleep. The present study examined the self-reported effect of cannabis use on individual's sleep-related problems. Participants included 311 individuals recruited online, who reported both sleep-related problems …
Ayahuasca’s Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness
Ayahuasca, a plant-based hallucinogen that serves as a spiritual medicine in South America, has improved depression in at least one placebo-controlled clinical trial. Case studies suggest that dramatic behavioral changes often follow the Ayahuasca ceremony, but most explanations of antidepressant effects focus on changes in mindfulness. This study investigated whether both mindfulness and behavioral activation might contribute to these anti-depre…
The Role of Impulsivity and Expectancies in Predicting Marijuana Use
Impulsivity and substance use covary. Smith and Anderson's acquired preparedness model proposes that impulsivity predicts substance use through a mediational model such that substance use expectancies mediate the relation between impulsivity and drug use. The present study seeks to examine the relation between positive urgency, an important component of impulsivity with specific relations to substance use behavior, marijuana expectancies, and mar…
Symptom specificity of ayahuasca's effect on depressive symptoms
BackgroundAyahuasca's effects on symptoms of depression have generated considerable optimism. Clients frequently report more concern about some symptoms than others, and available treatments alter symptoms differentially. Few studies address the symptom specificity of this psychoactive brew.AimsWe examined self-reported effects of ayahuasca on the individual symptoms of depression assessed by the 10-item short-form of Center for Epidemiological S…
The Role of Impulsivity and Expectancies in Predicting Marijuana Use
Impulsivity and substance use covary. Smith and Anderson's acquired preparedness model proposes that impulsivity predicts substance use through a mediational model such that substance use expectancies mediate the relation between impulsivity and drug use. The present study seeks to examine the relation between positive urgency, an important component of impulsivity with specific relations to substance use behavior, marijuana expectancies, and mar…
Cannabis Expectancies for Sleep
Up to 35% of adults in the United States suffer from sleep disturbances, which covary with a host of negative mental and physical health outcomes. Previous research suggests that cannabis' sedative effects may be associated with improved sleep. The present study examined the self-reported effect of cannabis use on individual's sleep-related problems. Participants included 311 individuals recruited online, who reported both sleep-related problems …
Ayahuasca’s Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness
Ayahuasca, a plant-based hallucinogen that serves as a spiritual medicine in South America, has improved depression in at least one placebo-controlled clinical trial. Case studies suggest that dramatic behavioral changes often follow the Ayahuasca ceremony, but most explanations of antidepressant effects focus on changes in mindfulness. This study investigated whether both mindfulness and behavioral activation might contribute to these anti-depre…
Expectancies about the Effects of Cannabis Use on Eating Disorder Symptoms
Background: Substance use, specifically cannabis use, is common among individuals with eating disorder (ED) symptoms; however, few studies have specifically explored the relation between EDs and cannabis use. Purpose: The present study examined expectancies about the impact of cannabis on cognitive, affective and behavioral ED symptoms. Additionally, this study explored associations between cannabis-related expectancies, cannabis use and cannabis…
Confirming Savoring’s Link to Fewer Cannabis Problems
Savoring has covaried inversely with cannabis problems and moderated the association between cannabis use and negative consequences related to use. Research has not yet addressed the acceptability of savoring interventions for cannabis users. The present study aimed to replicate the finding of savoring as a protective factor against problems for cannabis users. The second aim of the study was to examine preferences for a savoring intervention amo…
The Novelty of Ayahuasca Scale and the prediction of intentions to use
ObjectiveGiven the growing popularity of ayahuasca and other hallucinogens, we sought to identify related expectancies and their role in why people might use this psychoactive brew rather than classic hallucinogens like LSD or psilocybin.MethodExperienced users (N = 139) completed an online survey about their use of hallucinogens (including ayahuasca), how their ayahuasca experiences differed from those with other hallucinogens, as well as their …
Replicating the Dimensional Structure of Cannabis Problems
Objective: This study employed taxometric procedures to replicate a previous report of the dimensional structure of problems related to cannabis consumption. Method: Over 4,000 cannabis users completed an assessment of psychological, social, occupational, and physical harms (the Marijuana Problems Scale). Three taxometric procedures (MAMBAC, MAXEIG, and L-Mode) compared the current data to simulations with a base rate of problematic cannabis use …
Age-Related Differences in Cannabis Product Use
Cannabis use varies with age and gender, but less is known regarding specific product choices. Previous work suggests that older adults are inclined to stick to the more "classic" and familiar, while "novel" products are more likely to appeal to younger populations. We examined cross-sectional, retrospective data to determine whether the type of cannabis products used varied according to participant age ( N = 1406, 71.3% female). The extensive li…
Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression
Ketamine, a novel treatment for depression, has generated considerable interest and research. Few experiments address lay impressions of the credibility of ketamine treatment relative to another popular intervention for depression, CBT. Over 500 participants with depressive symptoms read descriptions of CBT, ketamine, and a treatment that combined the two. Descriptions included pros and cons of each approach. Participants found the combination tr…
Symptom specificity of ayahuasca's effect on depressive symptoms
BackgroundAyahuasca's effects on symptoms of depression have generated considerable optimism. Clients frequently report more concern about some symptoms than others, and available treatments alter symptoms differentially. Few studies address the symptom specificity of this psychoactive brew.AimsWe examined self-reported effects of ayahuasca on the individual symptoms of depression assessed by the 10-item short-form of Center for Epidemiological S…
How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression
Promising outcomes of Psilocybin-Assisted Therapy (PAT) for depression have generated concerted efforts to replicate, extend, and refine protocols to maximize efficacy. Psychotherapy research reveals that clients benefit most when important components of treatment align with their personal preferences. One open question related to PAT concerns the importance of the psilocybin experience of the guides (trained professionals present during acute ef…
Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression
Depression treatments succeed with many but leave others unimproved, and they can generate concerns about side effects, time, and cost. Psilocybin has generated media attention and empirical support for antidepressant effects, but lay impressions of its effectiveness are unclear. Although perceptions of treatment credibility contribute to outcome, beliefs about the credibility of psilocybin-assisted therapy (PAT) among potential patients remain u…
Methodological approach for an integrated female-specific study of anxiety and smoking comorbidity
Two primary ovarian hormones that fluctuate across the female menstrual cycle-estradiol and progesterone-have been independently linked in separate literatures to nicotine reinforcement and anxiety psychopathology. We identify existing methodological limitations in these literatures, describe an example protocol that was developed to address such limitations, highlight case examples, and offer insights on the resulting advantages and challenges. …
Client treatment preferences in psychedelic-assisted therapy for depression in participants with depressive symptoms
Background and AimsResearch on psychedelic-assisted therapy (PAT), a promising treatment option for major depression, has not revealed if potential clients show preferences about the demographic characteristics of providers comparable to those common in other forms of psychotherapy. Previous work suggests that honoring comparable client preferences can enhance therapeutic outcomes. This study aims to investigate the importance ratings for a same-…
Psychiatry (13 works) · Psychology (13 works) · Clinical Psychology (11 works) · Clinical Psychology (8 works) · Medicine (8 works) · Psychedelics and Drug Studies (7 works) · Cannabis and Cannabinoid Research (6 works) · Cannabis (5 works) · Cognition (5 works) · Psychotherapist (5 works)